DK1154792T3 - Tuberkulosevaccine-formulering, der omfatter monoglycerider eller fedtsyrer som adjuvans - Google Patents

Tuberkulosevaccine-formulering, der omfatter monoglycerider eller fedtsyrer som adjuvans

Info

Publication number: DK1154792T3
Authority: DK; Denmark
Prior art keywords: sub; adjuvant; fatty acids; monoglycerides; vaccine formulation
Prior art date: 1999-02-12

Application number

DK00906305T

Other languages

Danish (da)

English (en)

Inventor

Ulf Schroeder

Stefan Svenson

Original Assignee

Eurocine Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-02-12

Filing date

2000-02-09

Publication date

2007-02-12

2000-02-09 Application filed by Eurocine Ab filed Critical Eurocine Ab

2007-02-12 Application granted granted Critical

2007-02-12 Publication of DK1154792T3 publication Critical patent/DK1154792T3/da

Links

239000000203 mixture Substances 0.000 title abstract 3
239000002671 adjuvant Substances 0.000 title abstract 2
235000014113 dietary fatty acids Nutrition 0.000 title abstract 2
229930195729 fatty acid Natural products 0.000 title abstract 2
239000000194 fatty acid Substances 0.000 title abstract 2
150000004665 fatty acids Chemical class 0.000 title abstract 2
OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical class CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 title 1
238000009472 formulation Methods 0.000 title 1
229960002109 tuberculosis vaccine Drugs 0.000 title 1
LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 abstract 2
WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 abstract 2
201000008827 tuberculosis Diseases 0.000 abstract 2
241000187479 Mycobacterium tuberculosis Species 0.000 abstract 1
125000002252 acyl group Chemical group 0.000 abstract 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
230000003053 immunization Effects 0.000 abstract 1
238000002360 preparation method Methods 0.000 abstract 1
239000000126 substance Substances 0.000 abstract 1
229960005486 vaccine Drugs 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55505—Inorganic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Mycology (AREA)
Epidemiology (AREA)
Microbiology (AREA)
Immunology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Communicable Diseases (AREA)
Pulmonology (AREA)
Biochemistry (AREA)
Toxicology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

DK00906305T 1999-02-12 2000-02-09 Tuberkulosevaccine-formulering, der omfatter monoglycerider eller fedtsyrer som adjuvans DK1154792T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9900495A SE9900495D0 (sv)	1999-02-12	1999-02-12	Vaccine composition
PCT/EP2000/001046 WO2000047225A2 (fr)	1999-02-12	2000-02-09	Composition de vaccin

Publications (1)

Publication Number	Publication Date
DK1154792T3 true DK1154792T3 (da)	2007-02-12

Family

ID=20414469

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK00906305T DK1154792T3 (da)	1999-02-12	2000-02-09	Tuberkulosevaccine-formulering, der omfatter monoglycerider eller fedtsyrer som adjuvans

Country Status (10)

Country	Link
US (1)	US6936260B1 (fr)
EP (1)	EP1154792B1 (fr)
AT (1)	ATE342065T1 (fr)
AU (1)	AU769390B2 (fr)
DE (1)	DE60031243T2 (fr)
DK (1)	DK1154792T3 (fr)
ES (1)	ES2275495T3 (fr)
NZ (1)	NZ513130A (fr)
SE (1)	SE9900495D0 (fr)
WO (1)	WO2000047225A2 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AUPR030800A0 (en) *	2000-09-22	2000-10-12	Pharmalink International Limited	Immunomodulatory preparation
DE60226175T2 (de) *	2001-11-14	2009-07-09	Novavax, Inc.	Mycobakterieller impfstoff
CA2469334C (fr) *	2001-12-11	2012-05-08	Institut Pasteur	Preparations a base de bacteries gram positif destinees au traitement de maladies presentant un dysfonctionnement immunitaire
CU23476A1 (es) *	2004-01-29	2009-12-17	Ct Ingenieria Genetica Biotech	Formulación adyuvante conteniendo una emulsión oleosa con aceite de jojoba
CA2596920C (fr) *	2005-01-28	2015-05-05	North-West University	Combinaison de lipides et d'oxyde nitreux comme adjuvant permettant d'ameliorer l'efficacite de vaccins
DK2144626T3 (en) *	2007-04-12	2015-02-09	Mico Bio Inc	Tuberculosis vaccine and method of using same
CN102441162B (zh) *	2010-10-04	2018-07-24	免疫产品美国股份有限公司	结核病的治疗和预防
KR20140053887A (ko) *	2011-04-20	2014-05-08	미코 바이오, 인크.	면역 반응을 증진시키는 조성물 및 방법
EP2620159A1 (fr) *	2012-01-24	2013-07-31	Institut Pasteur	Traitement du cancer amélioré par immunothérapie par BCG ou des mycobactéries non pathogènes apparentées du point de vue des antigènes
WO2018006939A1 (fr)	2016-07-05	2018-01-11	Universidad De Zaragoza	Vaccin inactivé contre la tuberculose.
WO2020115161A1 (fr)	2018-12-04	2020-06-11	Sabiotec Spin-Off Sl	Immunostimulant destiné à être utilisé contre des pathogènes

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1990014837A1 (fr) *	1989-05-25	1990-12-13	Chiron Corporation	Composition d'adjuvant comprenant une emulsion de gouttelettes d'huile d'une taille inferieure au micron
WO1993006921A1 (fr)	1991-10-04	1993-04-15	Gs Biochem Ab	Particules, procede de preparation desdites particules et utilisations
DK17093D0 (da)	1993-02-15	1993-02-15	Lyfjathroun H F	Farmaceutisk praeparat til topisk administrering af antigener og/eller vacciner til pattedyr via slimhinder
ATE318147T1 (de) *	1996-03-25	2006-03-15	Medarex Inc	Spezifische monoklonale antikörperfür die extrazelluläre domäne von protasta-spezifischem membranantigen
SE9602280D0 (sv)	1996-06-10	1996-06-10	Pharmatrix Ab	Immunstimulerande lipidformulering

1999
- 1999-02-12 SE SE9900495A patent/SE9900495D0/xx unknown
2000
- 2000-02-09 WO PCT/EP2000/001046 patent/WO2000047225A2/fr not_active Ceased
- 2000-02-09 US US09/926,001 patent/US6936260B1/en not_active Expired - Fee Related
- 2000-02-09 ES ES00906305T patent/ES2275495T3/es not_active Expired - Lifetime
- 2000-02-09 EP EP00906305A patent/EP1154792B1/fr not_active Expired - Lifetime
- 2000-02-09 AU AU28035/00A patent/AU769390B2/en not_active Ceased
- 2000-02-09 DE DE60031243T patent/DE60031243T2/de not_active Expired - Lifetime
- 2000-02-09 DK DK00906305T patent/DK1154792T3/da active
- 2000-02-09 NZ NZ513130A patent/NZ513130A/xx not_active IP Right Cessation
- 2000-02-09 AT AT00906305T patent/ATE342065T1/de not_active IP Right Cessation

Also Published As

Publication number	Publication date
SE9900495D0 (sv)	1999-02-12
WO2000047225A2 (fr)	2000-08-17
AU769390B2 (en)	2004-01-22
US6936260B1 (en)	2005-08-30
ATE342065T1 (de)	2006-11-15
ES2275495T3 (es)	2007-06-16
EP1154792B1 (fr)	2006-10-11
DE60031243T2 (de)	2007-05-24
AU2803500A (en)	2000-08-29
NZ513130A (en)	2003-01-31
EP1154792A2 (fr)	2001-11-21
WO2000047225A3 (fr)	2000-12-14
DE60031243D1 (de)	2006-11-23

Publication	Publication Date	Title
DK0777490T3 (da)	2006-09-18	Mutant-enterotoxin, som er effektivt som et ikke-toksisk oralt adjuvans
NO20002741D0 (no)	2000-05-26	Vaksine-blandinger omfattende kitosan, for mukosal administrasjon
MD1586G2 (ro)	2001-10-31	Inducere a unui răspuns citotoxic T-limfocitar
NO20052010L (no)	2005-06-24	Immunogen sammensetning
NO976060L (no)	1998-02-17	Vaksiner mot hepatitt C
PT865297E (pt)	2003-03-31	Composicoes de vacinas para administracao intranasal compreendendo quitosano e suas utilizacoes
BRPI0000126B8 (pt)	2022-05-10	composição de vacina, composição adjuvante e método de produção de uma composição de vacina
BR9910296A (pt)	2002-01-15	Novos análogos graxos para o tratamento de obesidade, hipertensão e gordura no fìgado
DK0652773T3 (da)	1998-09-07	Anvendelse af nor- og homo-galdesyrederivater somabsorptionsfremmende bestanddele i lægemidler
EP2283858A3 (fr)	2011-03-23	Vaccin West Nile
SE9900495D0 (sv)	1999-02-12	Vaccine composition
DE69634024D1 (de)	2005-01-20	Adjuvans für vitale Impfstoffe
BR0111834A (pt)	2003-07-08	Composições adjuvante e imunogênica, e, método para eliciar uma resposta imune a um antìgeno
GB9306731D0 (en)	1993-05-26	Vaccines
SE9602280D0 (sv)	1996-06-10	Immunstimulerande lipidformulering
PT792165E (pt)	2004-02-27	Composicoes imunogenicas
DK1150713T3 (da)	2005-08-29	Vaccineformulering der omfatter monoglycerider eller fedtsyrer som adjuvans
SE0100011D0 (sv)	2001-01-03	Virus vaccine formulation
BR9713296A (pt)	1999-10-26	Processo para a preparação de derivados 2-amino-2-imidazolino, guanidino, e 2-amino-3,4,5,6-tetrahidro-pirimidina
ES2145541T3 (es)	2000-07-01	Nuevos seco-d-esteroides activos sobre el sistema cardiovascular, procedimientos para su preparacion y composiciones farmaceuticas que los contienen.
KR910002455A (ko)	1991-02-25	아크릴산 유도체를 함유하는 제약 조성물 및 의약으로서 이들의 사용
WO2002024147A3 (fr)	2002-06-27	Vaccin contre le pneumovirus aviaire
DK0617731T3 (da)	1995-07-24	N-acyl-phosphatidylethanolamin som oxidationsbeskyttelsesmiddel